マーケットレポート詳細
デジタルバイオマーカー：世界市場2026年予測
Digital Biomarkers: Global Markets
- 出版元：BCC Research
出版元について - 発行年：2022年3月
- 定価 Single User License(1名様ライセンス)US$5,500 (米国ドル) /2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文103ページになります。
- 商品コード：BCC389
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
デジタルバイオマーカーの世界市場規模は2021年18億ドルから、2026年までに72億ドルへと急速に成長する見通しです。期間中の同市場の平均年成長率は31.6%に達する見込みです。
精神疾患から筋骨格障害に至るまで様々な治療領域で、新たなデジタルヘルス技術によるソリューションの可能性が高まっています。長期間のモニタリングを必要とする慢性疾患の流行は、ウェアラブルやモバイルヘルスアプリの利用の増加に繋がっています。また、デジタルバイオマーカーの正確かつ定量的な分析は、製薬会社が従来のバイオマーカーとともに臨床試験におけるエンドポイントとしてこれらを採用する要因となっています。
当レポートでは、デジタルバイオマーカーの背景/技術、各種セグメント別市場分析(コンポーネント別、システムコンポーネント別、用途別、治療エリア別、エンドユーザー別、国地域別)、規制シナリオ、COVID-19の影響、競合状況、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
◆イントロダクション
・調査目的
・調査対象
・調査手法
◆サマリーと調査ハイライト
◆デジタルバイオマーカー：背景/技術
・概要
◆コンポーネント別、市場
・ソリューション
・サービス
◆市場ダイナミクス
◆システムコンポーネント別、市場
データ収集ツール
・ウェアラブル
・インプランタブル/インジェスティブル
・その他データ収集ツール
データ統合ツール
※システムコンポーネント別に地域別の細分化データ掲載（市場予測-2026年）
◆用途別、市場
・診断
・モニタリング
・予測
・その他
※用途別に地域別の細分化データ掲載（市場予測-2026年）
◆治療エリア別、市場
・CVMD (心血管/代謝障害)
・精神障害
・神経学
・呼吸器疾患
・筋骨格
・その他治療分野
※治療エリア別に地域別の細分化データ掲載（市場予測-2026年）
◆エンドユーザー別、市場
・製薬会社/研究機関
・医療提供者
・医療費負担者
・雇用主
・患者/介護者
※市場予測データ掲載-2026年
◆地域別、市場
北米
・米国、カナダ、メキシコ
欧州
・ドイツ、英国、ベルギー
・その他欧州
アジア太平洋
・日本、中国、オーストラリア
・その他アジア太平洋地域
その他地域
※地域別に国別の細分化データ掲載
※地域別にシステムコンポーネント別、用途別、治療エリア別の細分化データ掲載
◆規制シナリオ
・米国
・カナダ
・欧州
・アジア太平洋
◆COVID-19の影響
◆競合状況
・概要
・製薬会社
・テクノロジー企業 (大企業/中小企業)
・主要企業の最近の動向
・その他パートナーシップ/資金調達活動
◆主要企業プロフィール
ACTIGRAPH LLC
ALIVECOR INC.
AKILI INTERACTIVE LABS INC.
BIOGEN INC.
EMBIC CORP.
EVIDATION HEALTH INC.
FITBIT LLC
HAPPIFY HEALTH
HUMA
IXICO PLC
KONEKSA
MINDSTRONG HEALTH
WINTERLIGHT LABS
(全103頁)
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing this Study
Scope of this Report
Methodology
Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Market Highlights
Chapter 3 Digital Biomarkers: Background and Technology
Digital Biomarkers Overview
Chapter 4 Market Dynamics
Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
Chapter 5 Market Breakdown by System Component
Global Market for Digital Biomarkers
- Market Analysis
- Data Collection Tools
- Data Integration Tools
Chapter 6 Market Breakdown by Application
Diagnostic Digital Biomarkers
Monitoring Digital Biomarkers
Predictive Digital Biomarkers
Other Digital Biomarkers
Chapter 7 Market Breakdown by Therapeutic Area
Global Market for Digital Biomarkers by Therapeutic Area
CVMD
Psychiatric Disorders
Neurology
Respiratory Disorders
Musculoskeletal
Other Therapeutic Areas
Chapter 8 Market Breakdown by End User
Global Market for Digital Biomarkers by End User
Pharmaceutical Companies and Research Institutions
Healthcare Providers
Payers
Employers
Patients and Caregivers
Chapter 9 Market Breakdown by Region
Global Market for Digital Biomarkers by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 10 Regulatory Scenario
U.S.
Canada
Europe
Asia-Pacific
Chapter 11 Impact of the COVID-19 Pandemic
COVID-19’s Impact on the Digital Biomarker Market
Chapter 12 Competitive Landscape
Overview
Pharmaceutical Companies
Large Technology Companies
Small-Medium Sized Technology Companies
Recent Developments of Key Companies
Other Notable Partnerships and Funding Activities
Chapter 13 Company Profiles
ACTIGRAPH LLC
ALIVECOR INC.
AKILI INTERACTIVE LABS INC.
BIOGEN INC.
EMBIC CORP.
EVIDATION HEALTH INC.
FITBIT LLC
HAPPIFY HEALTH
HUMA
IXICO PLC
KONEKSA
MINDSTRONG HEALTH
WINTERLIGHT LABS
Chapter 14 Appendix: List of Acronyms"CC389
Digital Biomarkers: Global Markets
"List of Tables
Summary Table : Global Market for Digital Biomarkers, by System Component, Through 2026
Table 1 : Types of Digital Biomarkers
Table 2 : Comparison of Traditional and Digital Biomarkers
Table 3 : Digital Health Apps Globally, 2015-2021
Table 4 : Technology Innovations by Digital Biomarker Companies
Table 5 : Key Research Collaborations and Partnerships
Table 6 : Global Market for Digital Biomarkers, by System Component, Through 2026
Table 7 : Global Market for Data Collection Tools, by Region, Through 2026
Table 8 : Global Market for Data Collection Tools, by Type, Through 2026
Table 9 : Global Market for Mobile and Web Apps as Data Collection Tools, Through 2026
Table 10 : Global Market for Wearable Data Collection Tools, by Region, Through 2026
Table 11 : Global Market for Implantable and Ingestible Data Collection Tools, by Region, Through 2026
Table 12 : Global Market for Other Data Collection Tools, by Region, Through 2026
Table 13 : Global Market for Data Integration Tools, by Region, Through 2026
Table 14 : Global Market for Digital Biomarkers, by Application, Through 2026
Table 15 : Global Market for Diagnostic Digital Biomarkers, by Region, Through 2026
Table 16 : Global Market for Monitoring Digital Biomarkers, by Region, Through 2026
Table 17 : Global Market for Predictive Digital Biomarkers, by Region, Through 2026
Table 18 : Global Market for Other Digital Biomarkers, by Region, Through 2026
Table 19 : Global Market for Digital Biomarkers, by Therapeutic Area, Through 2026
Table 20 : Global Market for Digital Biomarkers for CVMD, by Region, Through 2026
Table 21 : Global Market for Digital Biomarkers for Psychiatric Disorders, by Region, Through 2026
Table 22 : Global Market for Digital Biomarkers for Neurology, by Region, Through 2026
Table 23 : Global Market for Digital Biomarkers for Respiratory Disorders, by Region, Through 2026
Table 24 : Global Market for Digital Biomarkers for Musculoskeletal, by Region, Through 2026
Table 25 : Global Market for Digital Biomarkers for Other Therapeutic Areas, by Region, Through 2026
Table 26 : Global Market for Digital Biomarkers, by End User, Through 2026
Table 27 : Global Market for Digital Biomarkers, by Region, Through 2026
Table 28 : North American Market for Digital Biomarkers, by Country, Through 2026
Table 29 : European Market for Digital Biomarkers, by Country, Through 2026
Table 30 : Asia-Pacific Market for Digital Biomarkers, by Country, Through 2026
Table 31 : Collaborations Between Pharmaceutical and Digital Biomarker Companies, 2021-2022
Table 32 : Actigraph LLC: Product Portfolio
Table 33 : Actigraph LLC: Key Developments
Table 34 : AliveCor: Product Portfolio
Table 35 : AliveCor: Key Developments
Table 36 : Akili Interactive Labs: Product Portfolio
Table 37 : Akili Interactive Labs: Key Developments
Table 38 : Biogen Product Portfolio
Table 39 : Embic: Product Portfolio
Table 40 : Evidation Health: Product Portfolio
Table 41 : Evidation Health: Key Developments
Table 42 : Fitbit: Product Portfolio
Table 43 : Fitbit: Key Developments
Table 44 : Happify Health: Product Portfolio
Table 45 : Happify Health: Key Developments
Table 46 : Huma: Product Portfolio
Table 47 : Ixico: Product Portfolio
Table 48 : Ixico: Key Developments
Table 49 : Koneksa Product Portfolio
Table 50 : Koneska: Key Developments
Table 51 : Mindstrong Health: Product Portfolio
Table 52 : Mindstrong Health: Key Developments
Table 53 : Winterlight Labs: Product Portfolio
Table 54 : Winterlight Labs: Key Developments
Table 55 : Acronyms Used in This Report
List of Figures
Summary Figure : Global Market for Digital Biomarkers, by System Component, 2019-2026
Figure 1 : Distribution of Clinical Trials with Digital Biomarkers as Endpoints by Therapeutic Area
Figure 2 : Global Shares of Digital Biomarker System Components, 2020
Figure 3 : Global Market for Data Collection Tools, by Region, 2019-2026
Figure 4 : Global Market Shares of Digital Biomarker Data Collection Tools, 2020
Figure 5 : Global Market for Data Integration Tools, by Region, 2019-2026
Figure 6 : Global Market Shares of Digital Biomarkers, by Application, 2020
Figure 7 : Global Market for Diagnostic Digital Biomarkers, 2019-2026
Figure 8 : Global Market for Monitoring Digital Biomarkers, 2019-2026
Figure 9 : Global Market for Predictive Digital Biomarkers, 2019-2026
Figure 10 : Global Market for Other Digital Biomarkers, 2019-2026
Figure 11 : Global Market Shares of Digital Biomarkers, by Therapeutic Area, 2020
Figure 12 : Global Market Shares of Digital Biomarkers, by End User, 2020
Figure 13 : Global Market for Digital Biomarkers, by End User, 2019-2026
Figure 14 : Global Market for Digital Biomarkers Used by Pharmaceutical Companies and Research Institutions, 2019-2026
Figure 15 : Global Market for Digital Biomarkers Used by Healthcare Providers, 2019-2026
Figure 16 : Global Market for Digital Biomarkers Used by Payers, 2019-2026
Figure 17 : Global Market for Digital Biomarkers Used by Employers, 2019-2026
Figure 18 : Global Market for Digital Biomarkers Used by Patients and Caregivers, 2019-2026
Figure 19 : Global Market Shares of Digital Biomarkers, by Region, 2020
Figure 20 : North American Market Shares of Digital Biomarkers, by Country, 2020
Figure 21 : U.S. Market for Digital Biomarkers, 2019-2026
Figure 22 : Canadian Market for Digital Biomarkers, 2019-2026
Figure 23 : Mexican Market for Digital Biomarkers, 2019-2026
Figure 24 : European Market Shares of Digital Biomarkers, by Country, 2020
Figure 25 : German Market for Digital Biomarkers, 2019-2026
Figure 26 : U.K. Market for Digital Biomarkers, 2019-2026
Figure 27 : Belgian Market for Digital Biomarkers, 2019-2026
Figure 28 : Rest of Europe Market for Digital Biomarkers, 2019-2026
Figure 29 : Asia-Pacific Market Shares of Digital Biomarkers, by Country, 2020
Figure 30 : Chinese Market for Digital Biomarkers, 2019-2026
Figure 31 : Australian Market for Digital Biomarkers, 2019-2026
Figure 32 : Japanese Market for Digital Biomarkers, 2019-2026
Figure 33 : Rest of Asia-Pacific Market for Digital Biomarkers, 2019-2026
Figure 34 : RoW Market for Digital Biomarkers, 2019-2026
Figure 35 : Digital Biomarkers: Competitor Types and Their Strategies
Figure 36 : Biogen: Annual Revenue, 2018-2020
Figure 37 : Biogen: Revenue Share, by Region, 2020
Figure 38 : Fitbit: Annual Revenue, 2019 and 2020
Figure 39 : Ixico: Annual Revenue, 2019 and 2020